Assessing the risk of tumor lysis syndrome associated with the use of antineoplastic agents: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database

• Main Authors: Dongxuan Li (Author), Chunmeng Qin (Author), Hongli Wang (Author), Dan Du (Author), Yalan Wang (Author), Qian Du (Author), Songqing Liu (Author)
• Format: Book
• Published: SAGE Publishing, 2024-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The use of antineoplastic agents is one of the important triggers of tumor lysis syndrome (TLS), but there is still a lack of comprehensive understanding of antineoplastic agents that may trigger TLS and the TLS risk differences between different antineoplastic agents. Objectives: This s...